BioNumerik, Grelan Pharmaceutical Co. deal

The companies agreed to develop BioNumerik's cisplatin-protecting agent, BNP7787, in Japan. BNP7787 is designed to protect against the drug's toxicities, which include kidney damage, nausea and vomit...